Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126680153 | 12668015 | 3 | F | 20160922 | 20160819 | 20160926 | EXP | PHEH2016US020439 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160926 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126680153 | 12668015 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Unknown | 20 MG, UNK | U | 21008 | 20 | MG | VIAL | ||||||
| 126680153 | 12668015 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Unknown | 30 MG, UNK | U | 21008 | 30 | MG | VIAL | ||||||
| 126680153 | 12668015 | 3 | SS | XANAX | ALPRAZOLAM | 1 | Unknown | 25 MG, QD (AT NIGHT) | U | 0 | 25 | MG | QD | ||||||
| 126680153 | 12668015 | 4 | C | AMOXICILLIN. | AMOXICILLIN | 1 | Unknown | U | 0 | ||||||||||
| 126680153 | 12668015 | 5 | C | ASPIRIN//ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | 81 MG, QD | U | 0 | 81 | MG | QD | ||||||
| 126680153 | 12668015 | 6 | C | FINASTERIDE. | FINASTERIDE | 1 | Unknown | 5 MG, QD (AT BEDTIME) | U | 0 | 5 | MG | QD | ||||||
| 126680153 | 12668015 | 7 | C | IRON | IRON | 1 | Unknown | 325 MG, BID | U | 0 | 325 | MG | BID | ||||||
| 126680153 | 12668015 | 8 | C | LOPERAMIDE HCL | LOPERAMIDE HYDROCHLORIDE | 1 | Unknown | UNK UNK, PRN | U | 0 | |||||||||
| 126680153 | 12668015 | 9 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Unknown | 400 MG, BID | U | 0 | 400 | MG | BID | ||||||
| 126680153 | 12668015 | 10 | C | NOVOLOG | INSULIN ASPART | 1 | Unknown | U | 0 | ||||||||||
| 126680153 | 12668015 | 11 | C | OXYGEN. | OXYGEN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126680153 | 12668015 | 12 | C | TORASEMIDE | TORSEMIDE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 126680153 | 12668015 | 13 | C | TAMSULOSIN | TAMSULOSIN | 1 | Unknown | UNK UNK, QD ONE AT BED TIME DAILY) | U | 0 | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126680153 | 12668015 | 1 | Product used for unknown indication |
| 126680153 | 12668015 | 3 | Product used for unknown indication |
| 126680153 | 12668015 | 4 | Fungal infection |
| 126680153 | 12668015 | 5 | Product used for unknown indication |
| 126680153 | 12668015 | 6 | Benign prostatic hyperplasia |
| 126680153 | 12668015 | 7 | Anaemia |
| 126680153 | 12668015 | 8 | Diarrhoea |
| 126680153 | 12668015 | 9 | Blood magnesium decreased |
| 126680153 | 12668015 | 10 | Product used for unknown indication |
| 126680153 | 12668015 | 11 | Product used for unknown indication |
| 126680153 | 12668015 | 12 | Blood pressure increased |
| 126680153 | 12668015 | 13 | Benign prostatic hyperplasia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126680153 | 12668015 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126680153 | 12668015 | Constipation | |
| 126680153 | 12668015 | Diabetes mellitus | |
| 126680153 | 12668015 | Dyspnoea | |
| 126680153 | 12668015 | Hepatic neoplasm | |
| 126680153 | 12668015 | Injection site mass | |
| 126680153 | 12668015 | Injection site pain | |
| 126680153 | 12668015 | Somnolence | |
| 126680153 | 12668015 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |